BriaCell Therapeutics Statistics
NASDAQ: BCTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.88-0.125 (-3.13%)
Market open · Delayed 15 min · as of Oct 8, 10:58 AM ET
BriaCell Therapeutics by the numbers
BriaCell Therapeutics has a market capitalization of $33.7 million based on 8.70M shares outstanding. With trailing EPS of $-0.92, BriaCell Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 3.2% above its 50-day average and 7.0% below its 200-day average.
Average daily trading volume is 280.62K shares, or about $1.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BCTX valuation vs. peer median
| Metric | BCTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $33.71M | $35.39M | -5% |
| Avg. volume | 280.62K | 120.39K | +133% |
Peer median across 8 companies: NNVC, ATNM, RMTI, LITS, IBO, FLNA, GRDX, IXHL.
Valuation
- Market cap
- $33.71M
- EPS (TTM)
- $-0.92
- Shares outstanding
- 8.70M
Price and trading
- Previous close
- 4.00
- Open
- 4.05
- Day range
- 3.88 – 4.05
- 52-week range
- 2.60 – 14.68
- 52-week change
- -68.33%
- Beta
- —
- Volume
- 9.63K
- Average volume
- 280.62K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 21, 2026
Additional statistics
- Market Cap
- 33.71M
- Forward Pe
- -9.94
- Eps
- -0.92
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 14.68
- Week52 Low
- 2.60
- Avg Volume
- 280.62K
- Shares Outstanding
- 8.70M
- Ma50
- 3.75
- Ma200
- 4.17
- Earnings Date
- Oct 21, 2026
- Pct From52w High
- -73.60%
- Pct From52w Low
- 49.04%